Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese Rheumatism Data Center

被引:8
作者
Li, Haoguang [1 ]
Zhang, Xiuling [1 ]
Yu, Le [1 ]
Shang, Jingjing [1 ]
Fan, Jie [1 ]
Feng, Xueqin [1 ]
Zhang, Rongwei [1 ]
Ren, Jie [1 ]
Guo, Qifang [1 ]
Duan, Xinwang [1 ]
机构
[1] Affiliated Hosp Nanchang Univ 2, Dept Rheumatol & Immunol, Nanchang, Jiangxi, Peoples R China
关键词
systemic sclerosis; clinical characteristic; interstitial lung disease (ILD); China; cross-sectional study; CUTANEOUS SUBSETS; DIGITAL ULCERS; KL-6; LEVELS; SCLERODERMA; SURVIVAL; FEATURES; COHORT; DEATH; CLASSIFICATION; ASSOCIATION;
D O I
10.3389/fmed.2022.1061738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWe aimed to compare the clinical characteristics of patients with systemic sclerosis (SSc) with or without interstitial lung disease (ILD) to identify relationships with the presence of ILD in SSc at a single center in China. MethodsA cross-sectional study was conducted using retrospective data from the Chinese Rheumatology Data Center. Patients diagnosed with SSc at the Second Affiliated Hospital of Nanchang University between 2013 and 2022 were included. Demographic and clinical characteristics were compared between patients with SSc with and without ILD. Logistic regression analyses were performed to explore these associations. ResultsA total of 227 patients with SSc were included (male:female ratio = 1:4.82), of which 121 (53.3%) were accompanied with ILD. SSc patients with ILD had a higher percentage of diffuse cutaneous systemic sclerosis (dcSSc), sclerodactyly, loss of finger pad, muscle involvement, left ventricular diastolic dysfunction (LVDD), and pulmonary hypertension (PAH), elevated Krebs von den Lungen-6 (KL-6), and elevated ferritin than those without ILD, and a higher modified Rodnan skin score (mRSS), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) (all P < 0.05). Antinuclear antibody (ANA) and anti-scleroderma-70 (anti-Scl-70) positivity was presented frequently in SSc patients with ILD, while SSc patients without ILD were more often anti-centromere antibody (ACA) positive (all P < 0.05). On the multivariable analysis, muscle involvement [OR 2.551 (95% CI 1.054-6.175), P = 0.038], LVDD [OR 2.360 (95% CI 1.277-4.361), P = 0.006], PAH [OR 9.134 (95% CI 2.335-35.730), P = 0.001], dcSSc [OR 2.859 (95% CI 1.489-5.487), P = 0.002], PLR [OR 1.005 (95% CI 1.001-1.008), P = 0.020], elevated KL-6 [OR 2.033 (95% CI 1.099-3.763), P = 0.024], and anti-Scl-70 [OR 3.101 (95% CI 1.647-5.840), P < 0.001] were statistically significant associations with SSc patients with ILD. ConclusionSystemic sclerosis was found mainly in females. Several important differences in clinical and laboratory characteristics have been demonstrated between SSc patients with or without ILD. Muscle involvement, LVDD, PAH, dcSSc, PLR, elevated KL-6, and Anti-Scl-70 antibody may be associated with SSc in patients with ILD.
引用
收藏
页数:9
相关论文
共 56 条
[1]  
Aguglia G, 2001, J RHEUMATOL, V28, P1563
[2]   Recent Advances in Understanding the Pathogenesis of Scleroderma-Interstitial Lung Disease [J].
Akter, Tanjina ;
Silver, Richard M. ;
Bogatkevich, Galina S. .
CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (04)
[3]   Ethnic Variations in Systemic Sclerosis Disease Manifestations, Internal Organ Involvement, and Mortality [J].
Al-Sheikh, Haifa ;
Ahmad, Zareen ;
Johnson, Sindhu R. .
JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) :1103-1108
[4]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[5]   Clinical features and prognostic factors of systemic sclerosis in Guangxi, China: Retrospective, single-center study of long-term survival in 470 patients [J].
Chen, Juan ;
Yang, Chenxi ;
Pan, Jie ;
Zhao, Cheng ;
Chen, Zhanrui ;
Wen, Jing ;
Dong, Fei ;
Liao, Xiaoling ;
Lei, Ling .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (02) :182-191
[6]   Gastroesophageal Reflux Incites Interstitial Lung Disease in Systemic Sclerosis: Clinical, Radiologic, Histopathologic, and Treatment Evidence [J].
Christmann, Romy B. ;
Wells, Athol U. ;
Capelozzi, Vera L. ;
Silver, Richard M. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 40 (03) :241-249
[7]   Predictors of progression in systemic sclerosis patients with interstitial lung disease [J].
Distler, Oliver ;
Assassi, Shervin ;
Cottin, Vincent ;
Cutolo, Maurizio ;
Danoff, Sonye K. ;
Denton, Christopher P. ;
Distler, Jorg H. W. ;
Hoffmann-Vold, Anna-Maria ;
Johnson, Sindhu R. ;
Ladner, Ulf Mueller ;
Smith, Vanessa ;
Volkmann, Elizabeth R. ;
Maher, Toby M. .
EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
[8]   Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease [J].
Elhai, Muriel ;
Hoffmann-Vold, Anna Maria ;
Avouac, Jerome ;
Pezet, Sonia ;
Cauvet, Anne ;
Leblond, Agathe ;
Fretheim, Havard ;
Garen, Torhild ;
Kuwana, Masataka ;
Molberg, Oyvind ;
Allanore, Yannick .
ARTHRITIS & RHEUMATOLOGY, 2019, 71 (06) :972-982
[9]   South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome [J].
Graf, Scott W. ;
Hakendorf, Paul ;
Lester, Sue ;
Patterson, Karen ;
Walker, Jenny G. ;
Smith, Malcolm. D. ;
Ahern, Michael J. ;
Roberts-Thomson, Peter J. .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (01) :102-109
[10]   Early Mortality in a Multinational Systemic Sclerosis Inception Cohort [J].
Hao, Yanjie ;
Hudson, Marie ;
Baron, Murray ;
Carreira, Patricia ;
Stevens, Wendy ;
Rabusa, Candice ;
Tatibouet, Solene ;
Carmona, Loreto ;
Joven, Beatriz E. ;
Huq, Molla ;
Proudman, Susanna ;
Nikpour, Mandana .
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (05) :1067-1077